RP-A601

23andMe Independent Board Directors Resign, Citing Lack of Progress on Take-Private Proposal

Sysmex Inostics Gets NYS CLEP Approval for Clinical Trial-Use Liquid Biopsy Assay

Abrinca Genomics Nabs CHF 150K From Venture Kick to Develop Microbial Genomics Analysis Platform

Proteomics Firm Nomic Bio Closes $42M Series B Round

Mount Sinai Health Launches Center for Undiagnosed Diseases With $3.3M NIH Grant